Design Therapeutics DSGN Cash Flow Statement (2020-2026)

NASDAQ DSGN
$15.13 +0.10 (+0.67%)
As of: Sep 4, 2026 · 3:58 PM EDT
Reported Financials

Design Therapeutics Quarterly Cash Flow Statement

Periods 26 quarters
Latest Jun 2026

Design Therapeutics reported cash from operations of -$15.52M and free cash flow of -$15.54M for the quarter ended Jun 2026, down 7.5% year over year. This cash flow statement covers 26 quarters of results from Mar 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-11.33M-11.37M-14.45M-16.63M-20.74M-18.89M-20.28M-22.61M-18.11M-5.87M-11.11M-14.00M-15.31M-16.29M-20.26M-21.82M-19.27M-18.18M-20.04M-23.39M
Share-based Compensation
1.24M1.56M5.06M5.32M5.28M3.08M7.91M8.01M9.11M2.72M10.71M10.68M10.63M3.47M13.46M13.78M13.86M3.44M17.32M17.42M
Cash from Operations
-8.16M-9.23M-11.83M-10.50M-13.90M-15.09M-17.42M-13.80M-14.53M-12.80M-12.44M-11.26M-9.55M-9.86M-16.79M-14.44M-11.16M-11.97M-16.43M-15.52M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles
-0.03M-0.03M-0.02M0.06M0.46M0.90M1.14M1.40M1.71M1.84M1.73M1.57M1.46M1.44M1.06M0.91M0.77M0.51M0.15M0.01M
Change in Working Capital
Change in Accured Expenses
1.37M-0.03M0.21M1.60M3.16M0.42M-1.75M3.07M0.24M-2.81M-2.52M-0.72M1.02M1.01M-0.30M0.54M2.40M1.84M-2.51M0.95M
Other Working Capital Changes
-0.47M-0.14M1.24M-0.22M1.90M0.47M-1.19M-0.60M0.64M-0.82M0.41M0.63M-0.66M-0.60M1.41M-0.45M-0.46M0.88M0.29M0.39M
Investing Activities
Capital Expenditures
0.97M0.35M0.08M0.24M0.31M0.29M0.09M0.09M0.05M0.03M0.20M0.16M-0.02M0.07M0.09M0.03M0.02M
Change in Acquisitions & Divestments
0.24M0.20M0.49M1.23M30.93M60.24M53.44M74.44M69.89M79.73M66.47M81.12M60.67M66.20M94.49M59.73M84.58M76.08M45.00M27.50M
Cash from Investing Activities
-5.04M-50.06M0.41M-156.96M-63.39M-1.06M19.73M11.98M15.27M5.55M20.62M27.33M-5.83M1.83M7.87M20.12M6.51M-11.58M-7.59M15.06M
Financing Activities
Other financing activities
0.16M0.15M0.02M0.01M0.40M0.02M0.01M0.00M0.01M0.02M0.04M0.18M0.03M0.14M
Change in Capital Stock
Net Shares Issued and Repurchased
1.44M2.50M3.13M2.58M5.30M2.50M2.82M3.15M3.93M3.75M
Net Equity Issued and Repurchased
19.91M
Misc.
Cash from Financing Activities
0.03M0.19M0.16M-0.20M0.15M0.13M0.01M0.50M0.02M0.23M0.00M0.26M0.02M0.36M0.04M25.32M19.93M0.60M
Change in Cash
-13.18M-59.09M-11.26M-167.66M-77.14M-16.02M2.31M-1.61M0.74M-6.74M8.20M16.30M-15.37M-7.76M-8.90M6.04M-4.62M1.77M-4.09M0.14M
Free Cash Flow
-9.13M-9.58M-11.90M-10.74M-14.21M-15.38M-17.51M-13.89M-14.59M-12.82M-12.63M-11.42M-9.53M-9.86M-16.86M-14.53M-11.16M-12.00M-16.43M-15.54M
Net Cash Flow
-13.18M-59.09M-11.26M-167.66M-77.14M-16.02M2.31M-1.82M0.74M-6.74M8.20M16.30M-15.37M-7.76M-8.90M6.04M-4.62M1.77M-4.09M0.14M